Published in Alcohol Clin Exp Res on May 01, 2000
Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res (2004) 1.45
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res (2008) 1.11
Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. Drug Alcohol Depend (2012) 1.08
Are treated alcoholics representative of the entire population with alcohol use disorders? A magnetic resonance study of brain injury. Alcohol (2008) 1.01
Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence. J Stud Alcohol Drugs (2010) 0.97
Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype? Alcohol Clin Exp Res (2008) 0.93
Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain". Exp Neurol (2008) 0.93
MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependence. NMR Biomed (2009) 0.92
Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res Notes (2014) 0.91
The Role of Glial Cells in Drug Abuse. Curr Drug Abuse Rev (2009) 0.90
Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res (2011) 0.89
High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism. MAGMA (2004) 0.82
Imaging neuroinflammation? A perspective from MR spectroscopy. Brain Pathol (2014) 0.82
Brain proton magnetic resonance spectroscopy of alcohol use disorders. Handb Clin Neurol (2014) 0.79
Metabolic abnormalities in lobar and subcortical brain regions of abstinent polysubstance users: magnetic resonance spectroscopic imaging. Alcohol Alcohol (2013) 0.78
MRI/MRS in neuroinflammation: methodology and applications. Clin Transl Imaging (2015) 0.77
HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation. Curr HIV Res (2014) 0.76
Neurochemical abnormalities in anterior cingulate cortex on betel quid dependence: a 2D (1)H MRS investigation. Am J Transl Res (2015) 0.75
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. Alcohol Res (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
The development of scales to measure social support for diet and exercise behaviors. Prev Med (1987) 7.22
Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria. Psychophysiology (2000) 5.83
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17
BEACHES: an observational system for assessing children's eating and physical activity behaviors and associated events. J Appl Behav Anal (1991) 3.61
The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57
Stimulus-independent thought depends on central executive resources. Mem Cognit (1995) 3.47
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med (1982) 3.30
Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc (1999) 3.11
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry (1999) 2.89
A multimodal assessment of driving performance in HIV infection. Neurology (2004) 2.81
The determination of low d5-phenylalanine enrichment (0.002-0.09 atom percent excess), after conversion to phenylethylamine, in relation to protein turnover studies by gas chromatography/electron ionization mass spectrometry. Rapid Commun Mass Spectrom (1992) 2.48
Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc (1999) 2.47
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology (2002) 2.47
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45
Vitreous cryopreservation maintains the function of vascular grafts. Nat Biotechnol (2000) 2.42
Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med (1994) 2.39
Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry (1988) 2.36
Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol (2001) 2.35
Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1982) 2.06
Introduction to background papers for the suggested changes to DSM-IV: cognitive disorders. J Neuropsychiatry Clin Neurosci (1992) 2.04
Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet (2001) 2.03
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
Stress, vulnerability and adult alcohol relapse. J Stud Alcohol (1995) 2.00
Cotransduction and cotransformation of genetic markers in Bacillus subtilis and Bacillus licheniformis. J Bacteriol (1969) 1.98
A factor analysis of the Klein sexual orientation grid in two disparate samples. Arch Sex Behav (1993) 1.98
A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol (1988) 1.96
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89
Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology (2000) 1.88
The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol (2001) 1.86
Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol (1987) 1.85
Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83
Television's influence on children's diet and physical activity. J Dev Behav Pediatr (1989) 1.77
The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc (1999) 1.75
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75
Blue-fluorescent antibodies. Science (2000) 1.71
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain (1999) 1.71
Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Ann Behav Med (1997) 1.68
Relation of cardiovascular fitness and physical activity to cardiovascular disease risk factors in children and adults. Am J Epidemiol (1988) 1.67
Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol (1998) 1.66
Analysis of covariance as a remedy for demographic mismatch of research subject groups: some sobering simulations. J Clin Exp Neuropsychol (1985) 1.66
The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment (1998) 1.65
Somatosensory evoked potentials for prediction of outcome in acute severe brain injury. J Pediatr (1995) 1.60
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60
Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction. Br J Ophthalmol (1981) 1.59
Thermal expansion measurements of frozen biological tissues at cryogenic temperatures. J Biomech Eng (1998) 1.56
Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1983) 1.55
Serial visual evoked potentials and outcome in term birth asphyxia. Pediatr Neurol (1991) 1.55
Meningoencephalitis associated with pneumonitis due to Mycoplasma pneumoniae. JAMA (1967) 1.55
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc (2011) 1.53
Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol (2007) 1.50
The Dependence of Protection against a Transplantable Mouse Leukemia upon the Genetic Constitution of the Immunizing Tissue. Proc Natl Acad Sci U S A (1935) 1.49
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology (2012) 1.48
Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res (1999) 1.47
Reduced mortality risk in alcoholics who achieve long-term abstinence. JAMA (1992) 1.46
Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol (1993) 1.45
Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44
Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am (1994) 1.43
Down-regulation of albumin synthesis in the rat by human recombinant interleukin-1 beta or turpentine and the response to nutrients. JPEN J Parenter Enteral Nutr (1996) 1.41
The unforgettable finger tourniquet. Injury (2003) 1.41
Mild neurocognitive disorder: needed addition to the nosology of cognitive impairment (organic mental) disorders. J Neuropsychiatry Clin Neurosci (1993) 1.40
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
The effect of African-American acculturation on neuropsychological test performance in normal and HIV-positive individuals. The HIV Neurobehavioral Research Center (HNRC) Group. J Int Neuropsychol Soc (1998) 1.39
Reorganizing the "organic" disorders. Hosp Community Psychiatry (1990) 1.39
Ex vivo delineation of placental angioarchitecture with the microbubble contrast agent Levovist. Am J Obstet Gynecol (2000) 1.39
Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol (1990) 1.38
Orientation of the valine-1 side chain of the gramicidin transmembrane channel and implications for channel functioning. A 2H NMR study. Biochemistry (1992) 1.38
Family variables and physical activity in preschool children. J Dev Behav Pediatr (1988) 1.36
Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med (1997) 1.34
Associations between migrant status and sexually transmitted infections among female sex workers in Tijuana, Mexico. Sex Transm Infect (2009) 1.33
Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates. Am J Clin Nutr (1999) 1.33
Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. Women Health (1993) 1.32
Amino acid infusion increases the sensitivity of muscle protein synthesis in vivo to insulin. Effect of branched-chain amino acids. Biochem J (1988) 1.27
Concurrent changes in transducing efficiency and content of transforming deoxyribonucleic acid in Bacillus subtilis bacteriophage SP-10. J Bacteriol (1966) 1.26
The sexual negotiation behavior of HIV-positive gay and bisexual men. J Consult Clin Psychol (2000) 1.26
Relationship of psychosocial factors to HIV disease progression. Ann Behav Med (1996) 1.24
Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology (2006) 1.23
Reduction of immune function in life stress and depression. Biol Psychiatry (1990) 1.23
A family approach to cardiovascular risk reduction: results from the San Diego Family Health Project. Health Educ Q (1989) 1.23
Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study. Pain (1991) 1.23
Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol (2008) 1.23
Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol (1997) 1.22
Characterization of factors and DNA sequences required for accurate transcription of the Saccharomyces cerevisiae 5 S RNA gene. J Biol Chem (1985) 1.22